LENS trial: Early treatment of diabetic retinopathy in T2DM is associated with reduced risks of disease progression and maculopathy

01 Sep 2025
LENS trial: Early treatment of diabetic retinopathy in T2DM is
associated with reduced risks of disease progression and macu
Professor Emeritus Dr Chan Siew Pheng shares a case study on diabetic retinopathy (DR) and discusses treatment strategies designed to slow disease progression and delay the need for laser therapy in patients.
Sponsored as an educational program by ABBOTT LABORATORIES (M) SDN. BHD

Related MIMS Drugs

Resources

MY-ABB-265

MY-ABB-265

MY-ABB-265

MY-ABB-265